{"gene":"ZFP42","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2012,"finding":"RNF12 (an X-encoded E3 ubiquitin ligase) directly ubiquitinates REX1, targeting it for proteasomal degradation. This RNF12-mediated degradation of REX1 initiates X-chromosome inactivation (XCI); REX1 binds to regulatory regions of Xist and Tsix, and its overexpression inhibits Xist transcription and XCI, while REX1 depletion in male ES cells causes ectopic XCI.","method":"Co-immunoprecipitation, ubiquitination assays, ChIP-seq, overexpression and knockout ES cell experiments, chromatin immunoprecipitation","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, ubiquitination assays, ChIP-seq, gain/loss-of-function) in a single rigorous study, replicated by a follow-up paper (PMID:30420655)","pmids":["22596162"],"is_preprint":false},{"year":2018,"finding":"REX1 is the critical (prime) target of RNF12 in X-chromosome inactivation. Genetic ablation of Rex1 in Rnf12-/- mice rescues the imprinted XCI failure phenotype, yielding viable, fertile Rnf12-/-:Rex1-/- female mice with normal imprinted and random XCI.","method":"Genetic rescue experiment (double-knockout mice), embryonic stem cell XCI assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic epistasis with double knockout rescue, replicating and extending the mechanistic finding from PMID:22596162","pmids":["30420655"],"is_preprint":false},{"year":1998,"finding":"The Rex-1 (Zfp-42) promoter is regulated by Oct-3/4, which can activate or repress it depending on cellular context. Oct-3/4 amino acids 1–35 mediate activation and amino acids 61–126 mediate repression. Oct-6 also represses Rex-1 via the same octamer site. A novel positive regulatory element adjacent to the octamer motif is bound by a protein(s) designated Rox-1 in undifferentiated F9 cells, and this binding is reduced after retinoic acid treatment.","method":"Promoter-deletion/mutation analysis, transient transfection, electrophoretic mobility shift assay (EMSA), E1A co-expression","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (deletion mapping, EMSA, transient transfection with domain-specific mutants) establishing direct transcriptional regulation","pmids":["9528758"],"is_preprint":false},{"year":2006,"finding":"Nanog is a direct transcriptional activator of the Rex-1 promoter in embryonic stem cells. Knockdown of Nanog reduces Rex-1 expression; forced Nanog expression in P19 cells stimulates Rex-1. The Nanog-responsive element maps between −187 and −286 of the Rex-1 promoter. Sox2 cooperates with Nanog to upregulate Rex-1, and Oct-3/4 also transactivates the Rex-1 promoter, but only Sox2 cooperates with Nanog.","method":"shRNA knockdown, luciferase reporter assay with serial deletions, overexpression in P19 cells, co-transfection analyses","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (knockdown, promoter deletion, co-transfection) in single lab establishing direct transcriptional regulation","pmids":["16714766"],"is_preprint":false},{"year":1993,"finding":"An octamer motif (ATTTGCAT) in the Rex-1 (Zfp-42) promoter is required for Rex-1 promoter activity in F9 stem cells and contributes to negative regulation by retinoic acid. The gene was mapped to mouse chromosome 8.","method":"Promoter-reporter assays, site-directed mutagenesis of octamer motif, chromosomal mapping, transgenic lacZ reporter in mouse embryos","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — promoter deletion/mutation with functional reporter assays, confirmed in vivo with transgenic embryo expression","pmids":["8474450"],"is_preprint":false},{"year":1994,"finding":"Oct-1 and Oct-3 bind the octamer motif in the Rex-1 promoter in F9 EC, D3 ES, and NT2/D1 EC cells. Upon retinoic acid-induced differentiation of F9 cells, the DNA/protein complex containing Oct-3 is lost while Oct-1 complexes persist, linking Oct-3 binding to active Rex-1 transcription.","method":"Electrophoretic mobility shift assay (EMSA), supershift analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — EMSA and supershift (single method) but replicated across multiple cell lines and consistent with functional data in PMID:9528758","pmids":["7945330"],"is_preprint":false},{"year":2002,"finding":"Rex-1 (Zfp-42) encodes a zinc finger transcription factor that regulates F9 cell differentiation along distinct lineages. Rex-1-/- F9 cells differentiate into parietal endoderm in the presence of retinoic acid alone (without cAMP), whereas wild-type cells require both stimuli. Rex-1-/- cells fail to express alpha-fetoprotein (a visceral endoderm marker) after RA treatment, indicating Rex-1 is required for VE differentiation.","method":"Homologous recombination gene targeting, molecular marker analysis (RT-PCR, Northern blot)","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with defined differentiation phenotypes, single lab","pmids":["12354678"],"is_preprint":false},{"year":2008,"finding":"Rex1/Zfp42 negatively regulates Janus kinase (JAK)/STAT signaling in stem cells. Loss of both Rex1 alleles in F9 cells leads to greatly increased STAT3 tyrosine phosphorylation and transcriptional activation of SOCS-3 (via STAT3-binding elements) upon RACT treatment, relative to wild-type cells. Dominant-negative Src, Jak2, and PKA partially reduce this SOCS-3 transcriptional increase in Rex1-null cells.","method":"Rex1 knockout F9 cells, promoter deletion/mutation luciferase assays, dominant-negative constructs, western blot for phospho-STAT3","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout cell lines with promoter mapping and phospho-signaling readout, single lab with multiple complementary methods","pmids":["18237746"],"is_preprint":false},{"year":2009,"finding":"Rex1 (Zfp42) disruption in ES cells enhances expression of ectoderm, mesoderm, and endoderm markers upon retinoic acid treatment, suggesting Rex1 acts to reduce RA-induced differentiation. Microarray analyses identified potential Rex1 target genes related to differentiation, cell cycle regulation, and cancer progression. Rex1-/- phenotypes were reversible upon Rex1 re-expression.","method":"Rex1 double-knockout ES cell lines (homologous recombination), microarray expression profiling, Rex1 overexpression rescue","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with defined phenotypic readouts and rescue, single lab; microarray adds breadth but lacks per-target mechanistic depth","pmids":["19618472"],"is_preprint":false},{"year":2011,"finding":"Rex1/Zfp42 binds chromatin at specific genomic loci in mouse ES cells, including bivalently marked Polycomb Group (PcG)-regulated developmental regulators. REX1 physically interacts with Ring1 proteins and PcG-associated proteins RYBP and YAF2, suggesting Rex1 fine-tunes pluripotency by modulating Polycomb-mediated gene regulation.","method":"Chromatin immunoprecipitation (ChIP), co-immunoprecipitation for protein interactions with Ring1A/B, RYBP, and YAF2","journal":"Stem cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — ChIP and Co-IP (two orthogonal methods) but single lab; cell-type specificity of ChIP binding shown by comparison in TS vs ES cells","pmids":["21530438"],"is_preprint":false},{"year":2011,"finding":"Rex1/Zfp42 null blastocysts show hypermethylation in the differentially methylated regions (DMRs) of Peg3 and Gnas imprinted domains (which contain YY1 binding sites). In vivo binding of Rex1 was confirmed only to the unmethylated allele of these two imprinted regions, suggesting Rex1 protects these DMRs from DNA methylation.","method":"Rex1-null mouse model (gene disruption), bisulfite sequencing of DMRs, chromatin immunoprecipitation for allele-specific binding","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo knockout with methylation analysis and allele-specific ChIP, single lab","pmids":["21233130"],"is_preprint":false},{"year":2012,"finding":"Rex1/Zfp42 associates with muERV-L retrotransposon elements in mouse ES cells (and to a lesser extent IAP and musD elements) as shown by ChIP. Rex1 depletion increases muERV-L expression; Rex1 gain and loss of function in pre-implantation embryos alters muERV-L levels. REX1 can associate with the lysine demethylase LSD1/KDM1A.","method":"Chromatin immunoprecipitation (ChIP), Rex1 siRNA depletion in ES cells, Rex1 gain/loss-of-function microinjection in pre-implantation embryos, co-immunoprecipitation with LSD1/KDM1A","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — ChIP and functional gain/loss-of-function in embryos plus Co-IP with LSD1, single lab with orthogonal methods","pmids":["22844087"],"is_preprint":false},{"year":2013,"finding":"REX1 is functionally important for human pluripotent stem cell (hPSC) self-renewal. REX1-depleted hPSCs lose self-renewal capacity. REX1 binds the promoters of cyclin B1/B2, positively regulating their transcription. Cyclin B/CDK1 phosphorylates DRP1 at Ser616, promoting mitochondrial fission and supporting glycolytic metabolism of hPSCs. REX1 expression improves reprogramming efficiency to pluripotency by lowering growth arrest and apoptosis barriers.","method":"shRNA knockdown, chromatin immunoprecipitation (ChIP) for REX1 binding to cyclin B1/B2 promoters, phospho-DRP1 western blot, mitochondrial imaging, reprogramming assays with factor replacement","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct promoter binding combined with functional knockdown and pathway readouts, single lab with multiple orthogonal methods","pmids":["23939908"],"is_preprint":false},{"year":2019,"finding":"REX1 transcriptionally suppresses SOCS1 (a JAK2/STAT3 pathway inhibitor) by binding to two specific regions of the SOCS1 promoter, activating the JAK2/STAT3 pathway and inducing epithelial-to-mesenchymal transition (EMT) with upregulation of VIMENTIN and downregulation of E-CADHERIN in cervical cancer cells.","method":"Dual-luciferase reporter assay, quantitative ChIP (qChIP), REX1 overexpression, in vivo xenograft metastasis assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct promoter binding confirmed by qChIP and luciferase reporter (two orthogonal methods), single lab","pmids":["31409905"],"is_preprint":false},{"year":2010,"finding":"REX1 directly binds to the MKK3 gene promoter, repressing MKK3 transcription and thereby suppressing p38 MAPK signaling. REX1 knockdown in human umbilical cord blood-derived MSCs increases p38 MAPK phosphorylation and MKK3 expression, reduces cell proliferation, impairs osteogenic differentiation, and increases adipogenic potential; these effects are rescued by p38 MAPK inhibition.","method":"Chromatin immunoprecipitation (ChIP) assay for REX1 binding to MKK3 promoter, lentiviral shRNA knockdown, p38 MAPK inhibitor rescue, differentiation assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — ChIP establishes direct binding with supporting functional readouts, single lab","pmids":["20463961"],"is_preprint":false},{"year":2007,"finding":"REX1 (ZFP42) is classified as a member of the YY1 sub-family of C2H2 zinc finger transcription factors, generated by retroposition from YY1 in placental mammals. REX1 binds to DNA motifs divergent from those of YY1, but sharing similarity at the 5'-CCAT-3' core region, indicating evolution of new DNA-binding specificity.","method":"Phylogenetic analysis, DNA-binding motif studies (in vitro binding assays)","journal":"Nucleic acids research","confidence":"Low","confidence_rationale":"Tier 4 / Moderate — DNA binding motif characterization, but methods are primarily bioinformatic/comparative with limited in vitro biochemical validation described in the abstract","pmids":["17478514"],"is_preprint":false},{"year":2010,"finding":"YY1 positively regulates human Rex-1 (hRex1) transcription in NT-2 and normal prostate epithelial (PrEC) cells. hRex1 protein binds to its own promoter at approximately −298 bp (a putative Rex1 binding site), positively autoregulating hRex1 transcription; this autoregulation is lost in PC-3 prostate cancer cells. EMSA confirmed reduced protein binding when the putative Rex1 binding site is mutated.","method":"Promoter-luciferase reporter assays with serial deletion constructs, co-transfection analyses, electrophoretic mobility shift assay (EMSA)","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — luciferase reporter deletions and EMSA provide direct evidence of binding and autoregulation, single lab","pmids":["20232320"],"is_preprint":false},{"year":2019,"finding":"HMGN proteins regulate Rex1 expression in mouse ES cells by recruiting transcription factors NANOG, OCT4, and SOX2 to an ESC-specific super enhancer in the 5' region of Rex1. Loss of HMGNs alters the local epigenetic landscape (increased H1, decreased active histone marks), reduces enhancer-promoter interactions (by 3C/conformation capture), and decreases transcription factor binding, downregulating Rex1 expression. Loss of HMGNs also reduces specific binding of REX1 protein to promoters and enhancers genome-wide.","method":"ChIP-seq, chromatin conformation capture (3C), HMGN knockout cells, histone modification analysis, transcription factor binding assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal chromatin methods (ChIP-seq, 3C, histone profiling) in single lab establishing indirect epigenetic mechanism","pmids":["30838422"],"is_preprint":false},{"year":2021,"finding":"REX-1 (ZFP42) recruits DNMT3b (DNA methyltransferase 3b) to the RASSF1a promoter, suppressing RASSF1a transcription via promoter methylation, and consequently activating MEK/ERK phosphorylation to promote tumor growth in prostate cancer.","method":"Co-immunoprecipitation (REX-1/DNMT3b interaction), bisulfite sequencing/methylation analysis of RASSF1a promoter, ChIP for DNMT3b recruitment, in vivo xenograft model, REX-1 overexpression/knockdown","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus ChIP plus methylation analysis, single lab with multiple complementary methods","pmids":["34183450"],"is_preprint":false}],"current_model":"ZFP42/REX1 is a YY1-related C2H2 zinc finger transcription factor expressed in pluripotent stem cells that (1) is targeted for proteasomal degradation by the E3 ubiquitin ligase RNF12, establishing a dose-dependent mechanism for initiating X-chromosome inactivation; (2) directly binds and regulates promoters of target genes including cyclin B1/B2 (activating mitochondrial fission via DRP1), MKK3 (repressing p38 MAPK signaling), SOCS1 (repressing JAK2/STAT3 inhibition), and RASSF1a (via DNMT3b-mediated methylation); (3) is transcriptionally regulated by Oct-3/4, Nanog, Sox2, and YY1 via an octamer motif and adjacent elements in its promoter, with Rex1 also autoregulating its own promoter; (4) associates with Polycomb-group proteins (Ring1A/B, RYBP, YAF2) and LSD1/KDM1A to modulate chromatin and endogenous retroviral element silencing; and (5) protects specific imprinted DMRs from hypermethylation in vivo."},"narrative":{"mechanistic_narrative":"ZFP42/REX1 is a C2H2 zinc finger transcription factor of the YY1 sub-family that operates as a sequence-specific chromatin-binding regulator in pluripotent stem cells, controlling pluripotency, lineage commitment, and X-chromosome inactivation [PMID:22596162, PMID:17478514]. Its own expression is governed by the core pluripotency network: an octamer motif in its promoter is bound by Oct-3/Oct-1, with Oct-3/4 acting as a context-dependent activator or repressor, while Nanog (cooperating with Sox2) and YY1 drive its transcription, and REX1 additionally autoregulates its own promoter [PMID:9528758, PMID:16714766, PMID:8474450, PMID:20232320]; HMGN proteins sustain this circuitry by maintaining an ESC-specific super-enhancer that recruits NANOG, OCT4, and SOX2 [PMID:30838422]. A central role for REX1 is in initiating X-chromosome inactivation: the X-encoded E3 ubiquitin ligase RNF12 directly ubiquitinates REX1 to target it for proteasomal degradation, and REX1 binds regulatory regions of Xist and Tsix to restrain Xist transcription, making REX1 the prime RNF12 target whose genetic ablation rescues the imprinted XCI failure of Rnf12-null mice [PMID:22596162, PMID:30420655]. At chromatin, REX1 binds bivalent Polycomb-regulated developmental loci and physically associates with Ring1 proteins, RYBP, YAF2, and the demethylase LSD1/KDM1A, and silences muERV-L endogenous retroviral elements [PMID:21530438, PMID:22844087]; it also protects the Peg3 and Gnas imprinted DMRs from hypermethylation in vivo [PMID:21233130]. As a direct promoter-binding transcription factor REX1 activates cyclin B1/B2 to drive CyclinB/CDK1-dependent DRP1 Ser616 phosphorylation, mitochondrial fission, and stem-cell self-renewal [PMID:23939908], represses MKK3 to dampen p38 MAPK signaling [PMID:20463961], and modulates lineage differentiation, limiting retinoic-acid-induced differentiation in F9 and ES cells [PMID:12354678, PMID:19618472]. In cancer contexts REX1 suppresses SOCS1 to activate JAK2/STAT3 and EMT and recruits DNMT3b to methylate and silence RASSF1a, activating MEK/ERK [PMID:18237746, PMID:31409905, PMID:34183450].","teleology":[{"year":1993,"claim":"Established that the Rex-1 promoter is built around an octamer motif essential for activity in stem cells and responsive to retinoic-acid-induced negative regulation, placing the gene under pluripotency-linked control.","evidence":"promoter-reporter and octamer site-directed mutagenesis with transgenic lacZ embryo reporters","pmids":["8474450"],"confidence":"High","gaps":["Did not identify the trans-acting factors binding the octamer","No protein-level function for REX1 itself addressed"]},{"year":1994,"claim":"Identified Oct-3 versus Oct-1 occupancy of the octamer motif as the switch coupling Rex-1 transcription to the undifferentiated state.","evidence":"EMSA and supershift across F9, D3, and NT2/D1 cells before and after RA differentiation","pmids":["7945330"],"confidence":"Medium","gaps":["Single-method binding evidence","No functional knockout of the Oct factors"]},{"year":1998,"claim":"Resolved that Oct-3/4 exerts both activating and repressive effects on Rex-1 through separable domains, revealing context-dependent regulation rather than a simple activator relationship.","evidence":"promoter deletion/mutation, transient transfection with domain-specific Oct mutants, and EMSA in F9 cells","pmids":["9528758"],"confidence":"High","gaps":["Identity of the Rox-1 positive-element factor unresolved","Mechanism of the activation/repression switch not defined"]},{"year":2002,"claim":"Demonstrated REX1 is functionally required for proper lineage choice, controlling visceral versus parietal endoderm differentiation in F9 cells.","evidence":"homologous-recombination knockout with marker analysis under RA/cAMP conditions","pmids":["12354678"],"confidence":"Medium","gaps":["No direct target genes identified","Single lineage system"]},{"year":2006,"claim":"Placed Rex-1 downstream of the pluripotency network by showing Nanog directly activates its promoter with Sox2 cooperation and Oct-3/4 transactivation.","evidence":"shRNA knockdown, serial-deletion luciferase reporters, and co-transfection in ES and P19 cells","pmids":["16714766"],"confidence":"High","gaps":["Direct vs indirect promoter contact not distinguished by ChIP","Combinatorial logic at the element not fully mapped"]},{"year":2007,"claim":"Defined REX1 as a YY1 sub-family C2H2 factor arising by retroposition with a divergent but related DNA-binding specificity, framing its molecular activity.","evidence":"phylogenetic analysis and in vitro DNA-binding motif studies","pmids":["17478514"],"confidence":"Low","gaps":["Primarily comparative/bioinformatic with limited biochemical validation","Genome-wide binding specificity not established"]},{"year":2008,"claim":"Linked REX1 to signaling control by showing it restrains JAK/STAT3 activation and SOCS-3 induction in stem cells.","evidence":"Rex1-null F9 cells, SOCS-3 promoter luciferase mapping, dominant-negative Src/Jak2/PKA, and phospho-STAT3 western blot","pmids":["18237746"],"confidence":"Medium","gaps":["Whether REX1 acts directly at signaling-gene promoters not shown","Single cell system"]},{"year":2009,"claim":"Broadened REX1's role to dampening multi-germ-layer differentiation and nominated candidate targets in cell cycle and differentiation programs.","evidence":"double-knockout ES cells with microarray profiling and re-expression rescue","pmids":["19618472"],"confidence":"Medium","gaps":["Microarray targets lack per-gene mechanistic validation","Direct vs indirect regulation not separated"]},{"year":2010,"claim":"Identified MKK3 as a direct REX1 repression target, defining a mechanism by which REX1 suppresses p38 MAPK to control MSC proliferation and lineage balance.","evidence":"ChIP at the MKK3 promoter, shRNA knockdown, and p38 inhibitor rescue with differentiation assays","pmids":["20463961"],"confidence":"Medium","gaps":["Single lab","No structural basis for promoter recognition"]},{"year":2010,"claim":"Showed YY1 drives human Rex1 and that REX1 positively autoregulates its own promoter, a circuit lost in prostate cancer cells.","evidence":"serial-deletion luciferase reporters, co-transfection, and EMSA in NT-2, PrEC, and PC-3 cells","pmids":["20232320"],"confidence":"Medium","gaps":["Cause of autoregulation loss in cancer cells not defined","Single-method binding confirmation"]},{"year":2011,"claim":"Connected REX1 to Polycomb-mediated chromatin regulation through binding of bivalent developmental loci and physical interaction with Ring1/RYBP/YAF2.","evidence":"ChIP and Co-IP with Ring1A/B, RYBP, and YAF2 in ES versus TS cells","pmids":["21530438"],"confidence":"Medium","gaps":["Functional consequence of the interactions on PRC1 activity not measured","Single lab"]},{"year":2011,"claim":"Established an in vivo genomic-imprinting function: REX1 protects Peg3 and Gnas DMRs from hypermethylation by allele-specific binding.","evidence":"Rex1-null blastocysts with bisulfite sequencing and allele-specific ChIP","pmids":["21233130"],"confidence":"Medium","gaps":["Mechanism by which REX1 binding blocks methylation unknown","Limited to two imprinted domains"]},{"year":2012,"claim":"Defined the RNF12–REX1 axis as the trigger of X-chromosome inactivation, showing direct ubiquitination/degradation of REX1 and REX1 occupancy of Xist/Tsix regulatory regions.","evidence":"Co-IP, ubiquitination assays, ChIP-seq, and gain/loss-of-function ES cell XCI experiments","pmids":["22596162"],"confidence":"High","gaps":["How REX1 dosage is quantitatively sensed for XCI timing not fully resolved","Structural basis of RNF12 recognition not shown"]},{"year":2012,"claim":"Extended REX1's chromatin role to endogenous retrovirus silencing, showing it represses muERV-L and associates with LSD1/KDM1A.","evidence":"ChIP, siRNA depletion in ES cells, embryo microinjection gain/loss-of-function, and Co-IP with LSD1","pmids":["22844087"],"confidence":"Medium","gaps":["Direct catalytic contribution of LSD1 at REX1 sites not dissected","Single lab"]},{"year":2013,"claim":"Provided a mechanism for REX1 in human pluripotent self-renewal by directly activating cyclin B1/B2 to drive CyclinB/CDK1–DRP1-dependent mitochondrial fission and glycolysis.","evidence":"shRNA knockdown, ChIP at cyclin B1/B2 promoters, phospho-DRP1 western, mitochondrial imaging, and reprogramming assays","pmids":["23939908"],"confidence":"Medium","gaps":["Whether cyclin regulation is conserved in mouse ES cells not addressed","Single lab"]},{"year":2019,"claim":"Showed REX1 can act oncogenically by directly repressing SOCS1, activating JAK2/STAT3 and driving EMT and metastasis in cervical cancer.","evidence":"dual-luciferase reporter, qChIP at the SOCS1 promoter, overexpression, and xenograft metastasis assays","pmids":["31409905"],"confidence":"Medium","gaps":["Generality across other tumor types not tested in this study","Single lab"]},{"year":2019,"claim":"Defined how the Rex1 super-enhancer is maintained, showing HMGN proteins recruit NANOG/OCT4/SOX2 and preserve enhancer-promoter contacts and active chromatin needed for Rex1 expression and genome-wide REX1 binding.","evidence":"ChIP-seq, chromatin conformation capture, and histone-modification profiling in HMGN-knockout ES cells","pmids":["30838422"],"confidence":"Medium","gaps":["Whether HMGN acts on REX1 directly or only through enhancer maintenance not separated","Single lab"]},{"year":2021,"claim":"Revealed a methylation-based repression mechanism in which REX1 recruits DNMT3b to silence RASSF1a and activate MEK/ERK, promoting prostate tumor growth.","evidence":"Co-IP, ChIP for DNMT3b recruitment, RASSF1a bisulfite methylation analysis, and xenograft model","pmids":["34183450"],"confidence":"Medium","gaps":["Sequence determinants of REX1–DNMT3b targeting unknown","Single lab"]},{"year":null,"claim":"How REX1's distinct activities — Polycomb/LSD1-linked silencing, DMR protection from methylation, versus DNMT3b-mediated promoter methylation — are differentially deployed at specific loci remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model for when REX1 protects versus promotes methylation","Structural basis of REX1 DNA recognition across target classes not defined","Cofactor selection rules between repressive and activating complexes unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,12,13,14,18]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,10,12,14,15,16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,9,10]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,3,12,14]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[9,10,11,18]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,8,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,13,14,18]}],"complexes":[],"partners":["RNF12","RING1","RYBP","YAF2","KDM1A","DNMT3B","YY1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96MM3","full_name":"Zinc finger protein 42 homolog","aliases":["Reduced expression protein 1","REX-1","hREX-1","Zinc finger protein 754"],"length_aa":310,"mass_kda":34.8,"function":"Involved in the reprogramming of X-chromosome inactivation during the acquisition of pluripotency. Required for efficient elongation of TSIX, a non-coding RNA antisense to XIST. Binds DXPas34 enhancer within the TSIX promoter. Involved in ES cell self-renewal (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96MM3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ZFP42","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ZFP42","total_profiled":1310},"omim":[{"mim_id":"614572","title":"ZINC FINGER PROTEIN 42; ZFP42","url":"https://www.omim.org/entry/614572"},{"mim_id":"611991","title":"MITOCHONDRIAL RIBOSOMAL PROTEIN S30; MRPS30","url":"https://www.omim.org/entry/611991"},{"mim_id":"607790","title":"TET METHYLCYTOSINE DIOXYGENASE 1; TET1","url":"https://www.omim.org/entry/607790"},{"mim_id":"300181","title":"X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE; TSIX","url":"https://www.omim.org/entry/300181"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"testis","ntpm":2.0}],"url":"https://www.proteinatlas.org/search/ZFP42"},"hgnc":{"alias_symbol":["REX1","ZNF754"],"prev_symbol":[]},"alphafold":{"accession":"Q96MM3","domains":[{"cath_id":"3.30.160","chopping":"244-273","consensus_level":"medium","plddt":89.9983,"start":244,"end":273},{"cath_id":"3.30.160","chopping":"274-304","consensus_level":"medium","plddt":89.5303,"start":274,"end":304}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96MM3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96MM3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96MM3-F1-predicted_aligned_error_v6.png","plddt_mean":56.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ZFP42","jax_strain_url":"https://www.jax.org/strain/search?query=ZFP42"},"sequence":{"accession":"Q96MM3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96MM3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96MM3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96MM3"}},"corpus_meta":[{"pmid":"11955434","id":"PMC_11955434","title":"P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11955434","citation_count":448,"is_preprint":false},{"pmid":"2787512","id":"PMC_2787512","title":"Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2787512","citation_count":291,"is_preprint":false},{"pmid":"1821852","id":"PMC_1821852","title":"Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes.","date":"1991","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1821852","citation_count":238,"is_preprint":false},{"pmid":"9528758","id":"PMC_9528758","title":"Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9528758","citation_count":206,"is_preprint":false},{"pmid":"24327733","id":"PMC_24327733","title":"PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24327733","citation_count":185,"is_preprint":false},{"pmid":"21172654","id":"PMC_21172654","title":"Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21172654","citation_count":173,"is_preprint":false},{"pmid":"2511439","id":"PMC_2511439","title":"Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells.","date":"1989","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2511439","citation_count":169,"is_preprint":false},{"pmid":"22596162","id":"PMC_22596162","title":"RNF12 initiates X-chromosome inactivation by targeting REX1 for degradation.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22596162","citation_count":167,"is_preprint":false},{"pmid":"22109529","id":"PMC_22109529","title":"P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.","date":"2011","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/22109529","citation_count":154,"is_preprint":false},{"pmid":"16714766","id":"PMC_16714766","title":"Regulation of the pluripotency marker Rex-1 by Nanog and Sox2.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16714766","citation_count":145,"is_preprint":false},{"pmid":"16243035","id":"PMC_16243035","title":"P-Rex1 regulates neutrophil function.","date":"2005","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16243035","citation_count":142,"is_preprint":false},{"pmid":"17565979","id":"PMC_17565979","title":"P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17565979","citation_count":130,"is_preprint":false},{"pmid":"19305425","id":"PMC_19305425","title":"Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19305425","citation_count":129,"is_preprint":false},{"pmid":"16243036","id":"PMC_16243036","title":"P-Rex1 is a primary Rac2 guanine nucleotide exchange factor in mouse neutrophils.","date":"2005","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16243036","citation_count":110,"is_preprint":false},{"pmid":"23939908","id":"PMC_23939908","title":"Unveiling the critical role of REX1 in the regulation of human stem cell pluripotency.","date":"2013","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/23939908","citation_count":101,"is_preprint":false},{"pmid":"15858067","id":"PMC_15858067","title":"Involvement of a Rac activator,P-Rex1, in neurotrophin-derived signaling and neuronal migration.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15858067","citation_count":98,"is_preprint":false},{"pmid":"18433507","id":"PMC_18433507","title":"Rex1/Zfp42 is dispensable for pluripotency in mouse ES cells.","date":"2008","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18433507","citation_count":95,"is_preprint":false},{"pmid":"17478514","id":"PMC_17478514","title":"Retroposition and evolution of the DNA-binding motifs of YY1, YY2 and REX1.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17478514","citation_count":91,"is_preprint":false},{"pmid":"21042280","id":"PMC_21042280","title":"P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21042280","citation_count":81,"is_preprint":false},{"pmid":"18456844","id":"PMC_18456844","title":"Competition between the Rex1 exonuclease and the La protein affects both Trf4p-mediated RNA quality control and pre-tRNA maturation.","date":"2008","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18456844","citation_count":81,"is_preprint":false},{"pmid":"25284585","id":"PMC_25284585","title":"P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25284585","citation_count":78,"is_preprint":false},{"pmid":"17698854","id":"PMC_17698854","title":"Membrane translocation of P-Rex1 is mediated by G protein betagamma subunits and phosphoinositide 3-kinase.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17698854","citation_count":73,"is_preprint":false},{"pmid":"18281244","id":"PMC_18281244","title":"Presumed pluripotency markers UTF-1 and REX-1 are expressed in human adult testes and germ cell neoplasms.","date":"2008","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18281244","citation_count":71,"is_preprint":false},{"pmid":"21178006","id":"PMC_21178006","title":"P-Rex1 and Vav1 cooperate in the regulation of formyl-methionyl-leucyl-phenylalanine-dependent neutrophil responses.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21178006","citation_count":70,"is_preprint":false},{"pmid":"21196713","id":"PMC_21196713","title":"Cytogenetic mapping of the retroelements Rex1, Rex3 and Rex6 among cichlid fish: new insights on the chromosomal distribution of transposable elements.","date":"2010","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/21196713","citation_count":66,"is_preprint":false},{"pmid":"31409905","id":"PMC_31409905","title":"REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31409905","citation_count":62,"is_preprint":false},{"pmid":"26621702","id":"PMC_26621702","title":"Synaptic P-Rex1 signaling regulates hippocampal long-term depression and autism-like social behavior.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26621702","citation_count":62,"is_preprint":false},{"pmid":"24659802","id":"PMC_24659802","title":"P-Rex1 directly activates RhoG to regulate GPCR-driven Rac signalling and actin polarity in neutrophils.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24659802","citation_count":59,"is_preprint":false},{"pmid":"20463961","id":"PMC_20463961","title":"REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20463961","citation_count":59,"is_preprint":false},{"pmid":"19618472","id":"PMC_19618472","title":"Analysis of Rex1 (zfp42) function in embryonic stem cell differentiation.","date":"2009","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/19618472","citation_count":58,"is_preprint":false},{"pmid":"22002247","id":"PMC_22002247","title":"Identification of P-Rex1 as a novel Rac1-guanine nucleotide exchange factor (GEF) that promotes actin remodeling and GLUT4 protein trafficking in adipocytes.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22002247","citation_count":58,"is_preprint":false},{"pmid":"8474450","id":"PMC_8474450","title":"An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8474450","citation_count":57,"is_preprint":false},{"pmid":"16793732","id":"PMC_16793732","title":"Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1.","date":"2006","source":"Cytotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/16793732","citation_count":53,"is_preprint":false},{"pmid":"26923603","id":"PMC_26923603","title":"P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26923603","citation_count":52,"is_preprint":false},{"pmid":"26112412","id":"PMC_26112412","title":"The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26112412","citation_count":52,"is_preprint":false},{"pmid":"24567914","id":"PMC_24567914","title":"Regulation of Mouse Retroelement MuERV-L/MERVL Expression by REX1 and Epigenetic Control of Stem Cell Potency.","date":"2014","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24567914","citation_count":50,"is_preprint":false},{"pmid":"16865673","id":"PMC_16865673","title":"The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures.","date":"2006","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16865673","citation_count":49,"is_preprint":false},{"pmid":"16301320","id":"PMC_16301320","title":"Phosphorylation of P-Rex1 by the cyclic AMP-dependent protein kinase inhibits the phosphatidylinositiol (3,4,5)-trisphosphate and Gbetagamma-mediated regulation of its activity.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16301320","citation_count":48,"is_preprint":false},{"pmid":"17227822","id":"PMC_17227822","title":"Signaling requirements for translocation of P-Rex1, a key Rac2 exchange factor involved in chemoattractant-stimulated human neutrophil function.","date":"2007","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/17227822","citation_count":46,"is_preprint":false},{"pmid":"17211834","id":"PMC_17211834","title":"Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression.","date":"2007","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17211834","citation_count":44,"is_preprint":false},{"pmid":"16273276","id":"PMC_16273276","title":"Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells.","date":"2005","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16273276","citation_count":43,"is_preprint":false},{"pmid":"22844087","id":"PMC_22844087","title":"Expression of endogenous retroviruses is negatively regulated by the pluripotency marker Rex1/Zfp42.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22844087","citation_count":42,"is_preprint":false},{"pmid":"18697831","id":"PMC_18697831","title":"P-Rex1 - a multidomain protein that regulates neurite differentiation.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/18697831","citation_count":42,"is_preprint":false},{"pmid":"18514484","id":"PMC_18514484","title":"Domain-domain interaction of P-Rex1 is essential for the activation and inhibition by G protein betagamma subunits and PKA.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18514484","citation_count":42,"is_preprint":false},{"pmid":"12354678","id":"PMC_12354678","title":"Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene.","date":"2002","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12354678","citation_count":42,"is_preprint":false},{"pmid":"21233130","id":"PMC_21233130","title":"Rex1/Zfp42 as an epigenetic regulator for genomic imprinting.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21233130","citation_count":41,"is_preprint":false},{"pmid":"28710285","id":"PMC_28710285","title":"P-Rex1 and P-Rex2 RacGEFs and cancer.","date":"2017","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/28710285","citation_count":39,"is_preprint":false},{"pmid":"23478800","id":"PMC_23478800","title":"Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1.","date":"2013","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23478800","citation_count":38,"is_preprint":false},{"pmid":"16301321","id":"PMC_16301321","title":"Differential sensitivity of P-Rex1 to isoforms of G protein betagamma dimers.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16301321","citation_count":37,"is_preprint":false},{"pmid":"26797121","id":"PMC_26797121","title":"Protein Kinase A (PKA) Type I Interacts with P-Rex1, a Rac Guanine Nucleotide Exchange Factor: EFFECT ON PKA LOCALIZATION AND P-Rex1 SIGNALING.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26797121","citation_count":36,"is_preprint":false},{"pmid":"25248717","id":"PMC_25248717","title":"Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.","date":"2014","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/25248717","citation_count":35,"is_preprint":false},{"pmid":"12697762","id":"PMC_12697762","title":"REX1, a novel gene required for DNA repair.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12697762","citation_count":33,"is_preprint":false},{"pmid":"30420655","id":"PMC_30420655","title":"REX1 is the critical target of RNF12 in imprinted X chromosome inactivation in mice.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30420655","citation_count":32,"is_preprint":false},{"pmid":"23382862","id":"PMC_23382862","title":"P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23382862","citation_count":32,"is_preprint":false},{"pmid":"24249226","id":"PMC_24249226","title":"tRNA 3' processing in yeast involves tRNase Z, Rex1, and Rrp6.","date":"2013","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/24249226","citation_count":32,"is_preprint":false},{"pmid":"31663027","id":"PMC_31663027","title":"Cryo-electron microscopy structure and analysis of the P-Rex1-Gβγ signaling scaffold.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31663027","citation_count":31,"is_preprint":false},{"pmid":"30446620","id":"PMC_30446620","title":"Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gαq and Gα13 proteins.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30446620","citation_count":31,"is_preprint":false},{"pmid":"22242915","id":"PMC_22242915","title":"The guanine-nucleotide-exchange factor P-Rex1 is activated by protein phosphatase 1α.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22242915","citation_count":31,"is_preprint":false},{"pmid":"23865932","id":"PMC_23865932","title":"Evolutionary dynamics of retrotransposable elements Rex1, Rex3 and Rex6 in neotropical cichlid genomes.","date":"2013","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/23865932","citation_count":31,"is_preprint":false},{"pmid":"7945330","id":"PMC_7945330","title":"The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells.","date":"1994","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7945330","citation_count":31,"is_preprint":false},{"pmid":"20798486","id":"PMC_20798486","title":"Chromosome mapping of retrotransposable elements Rex1 and Rex3 in three fish species in the subfamily Hypoptopomatinae (Teleostei, Siluriformes, Loricariidae).","date":"2010","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/20798486","citation_count":29,"is_preprint":false},{"pmid":"26792863","id":"PMC_26792863","title":"Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26792863","citation_count":26,"is_preprint":false},{"pmid":"20036214","id":"PMC_20036214","title":"Sphingosine-1-phosphate receptor S1P1 is regulated by direct interactions with P-Rex1, a Rac guanine nucleotide exchange factor.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20036214","citation_count":24,"is_preprint":false},{"pmid":"15749260","id":"PMC_15749260","title":"Effect of nicotine on Oct-4 and Rex-1 expression of mouse embryonic stem cells.","date":"2005","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15749260","citation_count":23,"is_preprint":false},{"pmid":"31900312","id":"PMC_31900312","title":"Discovery of Small Molecules That Target the Phosphatidylinositol (3,4,5) Trisphosphate (PIP3)-Dependent Rac Exchanger 1 (P-Rex1) PIP3-Binding Site and Inhibit P-Rex1-Dependent Functions in Neutrophils.","date":"2020","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31900312","citation_count":22,"is_preprint":false},{"pmid":"30530493","id":"PMC_30530493","title":"cAMP-dependent activation of the Rac guanine exchange factor P-REX1 by type I protein kinase A (PKA) regulatory subunits.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30530493","citation_count":22,"is_preprint":false},{"pmid":"16344273","id":"PMC_16344273","title":"Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.","date":"2005","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16344273","citation_count":22,"is_preprint":false},{"pmid":"24404417","id":"PMC_24404417","title":"Chromosome mapping of retrotransposable elements Rex1 and Rex3 in Leporinus Spix, 1829 species (Characiformes: Anostomidae) and its relationships among heterochromatic segments and W sex chromosome.","date":"2013","source":"Mobile genetic elements","url":"https://pubmed.ncbi.nlm.nih.gov/24404417","citation_count":20,"is_preprint":false},{"pmid":"23899556","id":"PMC_23899556","title":"Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells.","date":"2013","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/23899556","citation_count":20,"is_preprint":false},{"pmid":"27173636","id":"PMC_27173636","title":"Identification of P-Rex1 as an anti-inflammatory and anti-fibrogenic target for pulmonary fibrosis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27173636","citation_count":19,"is_preprint":false},{"pmid":"33097662","id":"PMC_33097662","title":"PtdIns(3,4,5)P3-dependent Rac exchanger 1 (P-Rex1) promotes mammary tumor initiation and metastasis.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33097662","citation_count":19,"is_preprint":false},{"pmid":"21530438","id":"PMC_21530438","title":"Association of Rex-1 to target genes supports its interaction with Polycomb function.","date":"2011","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/21530438","citation_count":19,"is_preprint":false},{"pmid":"23279369","id":"PMC_23279369","title":"IL-6 regulated stress-induced Rex-1 expression in stem cells from human exfoliated deciduous teeth.","date":"2012","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23279369","citation_count":19,"is_preprint":false},{"pmid":"28803992","id":"PMC_28803992","title":"P-REX1 amplification promotes progression of cutaneous melanoma via the PAK1/P38/MMP-2 pathway.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28803992","citation_count":18,"is_preprint":false},{"pmid":"20074642","id":"PMC_20074642","title":"Characterization of P-Rex1 for its role in fMet-Leu-Phe-induced superoxide production in reconstituted COS(phox) cells.","date":"2010","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20074642","citation_count":18,"is_preprint":false},{"pmid":"18237746","id":"PMC_18237746","title":"Transcriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cells.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18237746","citation_count":18,"is_preprint":false},{"pmid":"18502673","id":"PMC_18502673","title":"Lack of a significant role of P-Rex1, a major regulator of macrophage Rac1 activation and chemotaxis, in atherogenesis.","date":"2008","source":"Prostaglandins & other lipid mediators","url":"https://pubmed.ncbi.nlm.nih.gov/18502673","citation_count":18,"is_preprint":false},{"pmid":"21884615","id":"PMC_21884615","title":"Characterization of the Rac guanine nucleotide exchange factor P-Rex1 in platelets.","date":"2011","source":"Journal of molecular signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21884615","citation_count":17,"is_preprint":false},{"pmid":"20232320","id":"PMC_20232320","title":"Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20232320","citation_count":16,"is_preprint":false},{"pmid":"32661198","id":"PMC_32661198","title":"The first DEP domain of the RhoGEF P-Rex1 autoinhibits activity and contributes to membrane binding.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32661198","citation_count":16,"is_preprint":false},{"pmid":"27883224","id":"PMC_27883224","title":"Basic Fibroblast Growth Factor Regulates REX1 Expression Via IL-6 In Stem Cells Isolated From Human Exfoliated Deciduous Teeth.","date":"2016","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27883224","citation_count":16,"is_preprint":false},{"pmid":"32092966","id":"PMC_32092966","title":"P-REX1-Independent, Calcium-Dependent RAC1 Hyperactivation in Prostate Cancer.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32092966","citation_count":15,"is_preprint":false},{"pmid":"34183450","id":"PMC_34183450","title":"REX-1 Represses RASSF1a and Activates the MEK/ERK Pathway to Promote Tumorigenesis in Prostate Cancer.","date":"2021","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/34183450","citation_count":15,"is_preprint":false},{"pmid":"16472647","id":"PMC_16472647","title":"Purification of P-Rex1 from neutrophils and nucleotide exchange assay.","date":"2006","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16472647","citation_count":15,"is_preprint":false},{"pmid":"26651054","id":"PMC_26651054","title":"Development and Validation of a Rex1-RFP Potency Activity Reporter Assay That Quantifies Stress-Forced Potency Loss in Mouse Embryonic Stem Cells.","date":"2016","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/26651054","citation_count":15,"is_preprint":false},{"pmid":"31286410","id":"PMC_31286410","title":"P-Rex1 Overexpression Results in Aberrant Neuronal Polarity and Psychosis-Related Behaviors.","date":"2019","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/31286410","citation_count":14,"is_preprint":false},{"pmid":"22897771","id":"PMC_22897771","title":"Functional analysis of Rex1 during preimplantation development.","date":"2012","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/22897771","citation_count":14,"is_preprint":false},{"pmid":"27588611","id":"PMC_27588611","title":"The P-Rex1/Rac signaling pathway as a point of convergence for HER/ErbB receptor and GPCR responses.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/27588611","citation_count":13,"is_preprint":false},{"pmid":"36693952","id":"PMC_36693952","title":"The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer.","date":"2023","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/36693952","citation_count":13,"is_preprint":false},{"pmid":"33347743","id":"PMC_33347743","title":"P-Rex1 Mediates Glucose-Stimulated Rac1 Activation and Insulin Secretion in Pancreatic β-Cells.","date":"2020","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33347743","citation_count":13,"is_preprint":false},{"pmid":"27351228","id":"PMC_27351228","title":"Characterization of a P-Rex1 gene signature in breast cancer cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27351228","citation_count":13,"is_preprint":false},{"pmid":"31417979","id":"PMC_31417979","title":"Increased expression of stemness genes REX-1, OCT-4, NANOG, and SOX-2 in women with ovarian endometriosis versus normal endometrium: A case-control study.","date":"2019","source":"International journal of reproductive biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/31417979","citation_count":13,"is_preprint":false},{"pmid":"31737626","id":"PMC_31737626","title":"Rlim/Rnf12, Rex1, and X Chromosome Inactivation.","date":"2019","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31737626","citation_count":12,"is_preprint":false},{"pmid":"27788493","id":"PMC_27788493","title":"Multisite phosphorylation of P-Rex1 by protein kinase C.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27788493","citation_count":12,"is_preprint":false},{"pmid":"28698809","id":"PMC_28698809","title":"P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic Site.","date":"2017","source":"International journal of breast cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28698809","citation_count":12,"is_preprint":false},{"pmid":"30838422","id":"PMC_30838422","title":"Epigenetic regulation of REX1 expression and chromatin binding specificity by HMGNs.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30838422","citation_count":11,"is_preprint":false},{"pmid":"29983884","id":"PMC_29983884","title":"P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29983884","citation_count":11,"is_preprint":false},{"pmid":"33061433","id":"PMC_33061433","title":"Identification of P-Rex1 in the Regulation of Liver Cancer Cell Proliferation and Migration via HGF/c-Met/Akt Pathway.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33061433","citation_count":11,"is_preprint":false},{"pmid":"23661017","id":"PMC_23661017","title":"Induction of differentiation by down-regulation of Nanog and Rex-1 in cord blood derived unrestricted somatic stem cells.","date":"2013","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23661017","citation_count":11,"is_preprint":false},{"pmid":"25455130","id":"PMC_25455130","title":"IL-6 regulates stress-induced REX-1 expression via ATP-P2Y1 signalling in stem cells isolated from human exfoliated deciduous teeth.","date":"2014","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/25455130","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51450,"output_tokens":5231,"usd":0.116407,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13561,"output_tokens":5099,"usd":0.09764,"stage2_stop_reason":"end_turn"},"total_usd":0.214047,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"RNF12 (an X-encoded E3 ubiquitin ligase) directly ubiquitinates REX1, targeting it for proteasomal degradation. This RNF12-mediated degradation of REX1 initiates X-chromosome inactivation (XCI); REX1 binds to regulatory regions of Xist and Tsix, and its overexpression inhibits Xist transcription and XCI, while REX1 depletion in male ES cells causes ectopic XCI.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, ChIP-seq, overexpression and knockout ES cell experiments, chromatin immunoprecipitation\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, ubiquitination assays, ChIP-seq, gain/loss-of-function) in a single rigorous study, replicated by a follow-up paper (PMID:30420655)\",\n      \"pmids\": [\"22596162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"REX1 is the critical (prime) target of RNF12 in X-chromosome inactivation. Genetic ablation of Rex1 in Rnf12-/- mice rescues the imprinted XCI failure phenotype, yielding viable, fertile Rnf12-/-:Rex1-/- female mice with normal imprinted and random XCI.\",\n      \"method\": \"Genetic rescue experiment (double-knockout mice), embryonic stem cell XCI assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic epistasis with double knockout rescue, replicating and extending the mechanistic finding from PMID:22596162\",\n      \"pmids\": [\"30420655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The Rex-1 (Zfp-42) promoter is regulated by Oct-3/4, which can activate or repress it depending on cellular context. Oct-3/4 amino acids 1–35 mediate activation and amino acids 61–126 mediate repression. Oct-6 also represses Rex-1 via the same octamer site. A novel positive regulatory element adjacent to the octamer motif is bound by a protein(s) designated Rox-1 in undifferentiated F9 cells, and this binding is reduced after retinoic acid treatment.\",\n      \"method\": \"Promoter-deletion/mutation analysis, transient transfection, electrophoretic mobility shift assay (EMSA), E1A co-expression\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (deletion mapping, EMSA, transient transfection with domain-specific mutants) establishing direct transcriptional regulation\",\n      \"pmids\": [\"9528758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nanog is a direct transcriptional activator of the Rex-1 promoter in embryonic stem cells. Knockdown of Nanog reduces Rex-1 expression; forced Nanog expression in P19 cells stimulates Rex-1. The Nanog-responsive element maps between −187 and −286 of the Rex-1 promoter. Sox2 cooperates with Nanog to upregulate Rex-1, and Oct-3/4 also transactivates the Rex-1 promoter, but only Sox2 cooperates with Nanog.\",\n      \"method\": \"shRNA knockdown, luciferase reporter assay with serial deletions, overexpression in P19 cells, co-transfection analyses\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (knockdown, promoter deletion, co-transfection) in single lab establishing direct transcriptional regulation\",\n      \"pmids\": [\"16714766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"An octamer motif (ATTTGCAT) in the Rex-1 (Zfp-42) promoter is required for Rex-1 promoter activity in F9 stem cells and contributes to negative regulation by retinoic acid. The gene was mapped to mouse chromosome 8.\",\n      \"method\": \"Promoter-reporter assays, site-directed mutagenesis of octamer motif, chromosomal mapping, transgenic lacZ reporter in mouse embryos\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — promoter deletion/mutation with functional reporter assays, confirmed in vivo with transgenic embryo expression\",\n      \"pmids\": [\"8474450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Oct-1 and Oct-3 bind the octamer motif in the Rex-1 promoter in F9 EC, D3 ES, and NT2/D1 EC cells. Upon retinoic acid-induced differentiation of F9 cells, the DNA/protein complex containing Oct-3 is lost while Oct-1 complexes persist, linking Oct-3 binding to active Rex-1 transcription.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), supershift analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — EMSA and supershift (single method) but replicated across multiple cell lines and consistent with functional data in PMID:9528758\",\n      \"pmids\": [\"7945330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Rex-1 (Zfp-42) encodes a zinc finger transcription factor that regulates F9 cell differentiation along distinct lineages. Rex-1-/- F9 cells differentiate into parietal endoderm in the presence of retinoic acid alone (without cAMP), whereas wild-type cells require both stimuli. Rex-1-/- cells fail to express alpha-fetoprotein (a visceral endoderm marker) after RA treatment, indicating Rex-1 is required for VE differentiation.\",\n      \"method\": \"Homologous recombination gene targeting, molecular marker analysis (RT-PCR, Northern blot)\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with defined differentiation phenotypes, single lab\",\n      \"pmids\": [\"12354678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Rex1/Zfp42 negatively regulates Janus kinase (JAK)/STAT signaling in stem cells. Loss of both Rex1 alleles in F9 cells leads to greatly increased STAT3 tyrosine phosphorylation and transcriptional activation of SOCS-3 (via STAT3-binding elements) upon RACT treatment, relative to wild-type cells. Dominant-negative Src, Jak2, and PKA partially reduce this SOCS-3 transcriptional increase in Rex1-null cells.\",\n      \"method\": \"Rex1 knockout F9 cells, promoter deletion/mutation luciferase assays, dominant-negative constructs, western blot for phospho-STAT3\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout cell lines with promoter mapping and phospho-signaling readout, single lab with multiple complementary methods\",\n      \"pmids\": [\"18237746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Rex1 (Zfp42) disruption in ES cells enhances expression of ectoderm, mesoderm, and endoderm markers upon retinoic acid treatment, suggesting Rex1 acts to reduce RA-induced differentiation. Microarray analyses identified potential Rex1 target genes related to differentiation, cell cycle regulation, and cancer progression. Rex1-/- phenotypes were reversible upon Rex1 re-expression.\",\n      \"method\": \"Rex1 double-knockout ES cell lines (homologous recombination), microarray expression profiling, Rex1 overexpression rescue\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with defined phenotypic readouts and rescue, single lab; microarray adds breadth but lacks per-target mechanistic depth\",\n      \"pmids\": [\"19618472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rex1/Zfp42 binds chromatin at specific genomic loci in mouse ES cells, including bivalently marked Polycomb Group (PcG)-regulated developmental regulators. REX1 physically interacts with Ring1 proteins and PcG-associated proteins RYBP and YAF2, suggesting Rex1 fine-tunes pluripotency by modulating Polycomb-mediated gene regulation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), co-immunoprecipitation for protein interactions with Ring1A/B, RYBP, and YAF2\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — ChIP and Co-IP (two orthogonal methods) but single lab; cell-type specificity of ChIP binding shown by comparison in TS vs ES cells\",\n      \"pmids\": [\"21530438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rex1/Zfp42 null blastocysts show hypermethylation in the differentially methylated regions (DMRs) of Peg3 and Gnas imprinted domains (which contain YY1 binding sites). In vivo binding of Rex1 was confirmed only to the unmethylated allele of these two imprinted regions, suggesting Rex1 protects these DMRs from DNA methylation.\",\n      \"method\": \"Rex1-null mouse model (gene disruption), bisulfite sequencing of DMRs, chromatin immunoprecipitation for allele-specific binding\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo knockout with methylation analysis and allele-specific ChIP, single lab\",\n      \"pmids\": [\"21233130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rex1/Zfp42 associates with muERV-L retrotransposon elements in mouse ES cells (and to a lesser extent IAP and musD elements) as shown by ChIP. Rex1 depletion increases muERV-L expression; Rex1 gain and loss of function in pre-implantation embryos alters muERV-L levels. REX1 can associate with the lysine demethylase LSD1/KDM1A.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), Rex1 siRNA depletion in ES cells, Rex1 gain/loss-of-function microinjection in pre-implantation embryos, co-immunoprecipitation with LSD1/KDM1A\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — ChIP and functional gain/loss-of-function in embryos plus Co-IP with LSD1, single lab with orthogonal methods\",\n      \"pmids\": [\"22844087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"REX1 is functionally important for human pluripotent stem cell (hPSC) self-renewal. REX1-depleted hPSCs lose self-renewal capacity. REX1 binds the promoters of cyclin B1/B2, positively regulating their transcription. Cyclin B/CDK1 phosphorylates DRP1 at Ser616, promoting mitochondrial fission and supporting glycolytic metabolism of hPSCs. REX1 expression improves reprogramming efficiency to pluripotency by lowering growth arrest and apoptosis barriers.\",\n      \"method\": \"shRNA knockdown, chromatin immunoprecipitation (ChIP) for REX1 binding to cyclin B1/B2 promoters, phospho-DRP1 western blot, mitochondrial imaging, reprogramming assays with factor replacement\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct promoter binding combined with functional knockdown and pathway readouts, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23939908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"REX1 transcriptionally suppresses SOCS1 (a JAK2/STAT3 pathway inhibitor) by binding to two specific regions of the SOCS1 promoter, activating the JAK2/STAT3 pathway and inducing epithelial-to-mesenchymal transition (EMT) with upregulation of VIMENTIN and downregulation of E-CADHERIN in cervical cancer cells.\",\n      \"method\": \"Dual-luciferase reporter assay, quantitative ChIP (qChIP), REX1 overexpression, in vivo xenograft metastasis assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct promoter binding confirmed by qChIP and luciferase reporter (two orthogonal methods), single lab\",\n      \"pmids\": [\"31409905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"REX1 directly binds to the MKK3 gene promoter, repressing MKK3 transcription and thereby suppressing p38 MAPK signaling. REX1 knockdown in human umbilical cord blood-derived MSCs increases p38 MAPK phosphorylation and MKK3 expression, reduces cell proliferation, impairs osteogenic differentiation, and increases adipogenic potential; these effects are rescued by p38 MAPK inhibition.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) assay for REX1 binding to MKK3 promoter, lentiviral shRNA knockdown, p38 MAPK inhibitor rescue, differentiation assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — ChIP establishes direct binding with supporting functional readouts, single lab\",\n      \"pmids\": [\"20463961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"REX1 (ZFP42) is classified as a member of the YY1 sub-family of C2H2 zinc finger transcription factors, generated by retroposition from YY1 in placental mammals. REX1 binds to DNA motifs divergent from those of YY1, but sharing similarity at the 5'-CCAT-3' core region, indicating evolution of new DNA-binding specificity.\",\n      \"method\": \"Phylogenetic analysis, DNA-binding motif studies (in vitro binding assays)\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Moderate — DNA binding motif characterization, but methods are primarily bioinformatic/comparative with limited in vitro biochemical validation described in the abstract\",\n      \"pmids\": [\"17478514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"YY1 positively regulates human Rex-1 (hRex1) transcription in NT-2 and normal prostate epithelial (PrEC) cells. hRex1 protein binds to its own promoter at approximately −298 bp (a putative Rex1 binding site), positively autoregulating hRex1 transcription; this autoregulation is lost in PC-3 prostate cancer cells. EMSA confirmed reduced protein binding when the putative Rex1 binding site is mutated.\",\n      \"method\": \"Promoter-luciferase reporter assays with serial deletion constructs, co-transfection analyses, electrophoretic mobility shift assay (EMSA)\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — luciferase reporter deletions and EMSA provide direct evidence of binding and autoregulation, single lab\",\n      \"pmids\": [\"20232320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HMGN proteins regulate Rex1 expression in mouse ES cells by recruiting transcription factors NANOG, OCT4, and SOX2 to an ESC-specific super enhancer in the 5' region of Rex1. Loss of HMGNs alters the local epigenetic landscape (increased H1, decreased active histone marks), reduces enhancer-promoter interactions (by 3C/conformation capture), and decreases transcription factor binding, downregulating Rex1 expression. Loss of HMGNs also reduces specific binding of REX1 protein to promoters and enhancers genome-wide.\",\n      \"method\": \"ChIP-seq, chromatin conformation capture (3C), HMGN knockout cells, histone modification analysis, transcription factor binding assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal chromatin methods (ChIP-seq, 3C, histone profiling) in single lab establishing indirect epigenetic mechanism\",\n      \"pmids\": [\"30838422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"REX-1 (ZFP42) recruits DNMT3b (DNA methyltransferase 3b) to the RASSF1a promoter, suppressing RASSF1a transcription via promoter methylation, and consequently activating MEK/ERK phosphorylation to promote tumor growth in prostate cancer.\",\n      \"method\": \"Co-immunoprecipitation (REX-1/DNMT3b interaction), bisulfite sequencing/methylation analysis of RASSF1a promoter, ChIP for DNMT3b recruitment, in vivo xenograft model, REX-1 overexpression/knockdown\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus ChIP plus methylation analysis, single lab with multiple complementary methods\",\n      \"pmids\": [\"34183450\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ZFP42/REX1 is a YY1-related C2H2 zinc finger transcription factor expressed in pluripotent stem cells that (1) is targeted for proteasomal degradation by the E3 ubiquitin ligase RNF12, establishing a dose-dependent mechanism for initiating X-chromosome inactivation; (2) directly binds and regulates promoters of target genes including cyclin B1/B2 (activating mitochondrial fission via DRP1), MKK3 (repressing p38 MAPK signaling), SOCS1 (repressing JAK2/STAT3 inhibition), and RASSF1a (via DNMT3b-mediated methylation); (3) is transcriptionally regulated by Oct-3/4, Nanog, Sox2, and YY1 via an octamer motif and adjacent elements in its promoter, with Rex1 also autoregulating its own promoter; (4) associates with Polycomb-group proteins (Ring1A/B, RYBP, YAF2) and LSD1/KDM1A to modulate chromatin and endogenous retroviral element silencing; and (5) protects specific imprinted DMRs from hypermethylation in vivo.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ZFP42/REX1 is a C2H2 zinc finger transcription factor of the YY1 sub-family that operates as a sequence-specific chromatin-binding regulator in pluripotent stem cells, controlling pluripotency, lineage commitment, and X-chromosome inactivation [#0, #15]. Its own expression is governed by the core pluripotency network: an octamer motif in its promoter is bound by Oct-3/Oct-1, with Oct-3/4 acting as a context-dependent activator or repressor, while Nanog (cooperating with Sox2) and YY1 drive its transcription, and REX1 additionally autoregulates its own promoter [#2, #3, #4, #16]; HMGN proteins sustain this circuitry by maintaining an ESC-specific super-enhancer that recruits NANOG, OCT4, and SOX2 [#17]. A central role for REX1 is in initiating X-chromosome inactivation: the X-encoded E3 ubiquitin ligase RNF12 directly ubiquitinates REX1 to target it for proteasomal degradation, and REX1 binds regulatory regions of Xist and Tsix to restrain Xist transcription, making REX1 the prime RNF12 target whose genetic ablation rescues the imprinted XCI failure of Rnf12-null mice [#0, #1]. At chromatin, REX1 binds bivalent Polycomb-regulated developmental loci and physically associates with Ring1 proteins, RYBP, YAF2, and the demethylase LSD1/KDM1A, and silences muERV-L endogenous retroviral elements [#9, #11]; it also protects the Peg3 and Gnas imprinted DMRs from hypermethylation in vivo [#10]. As a direct promoter-binding transcription factor REX1 activates cyclin B1/B2 to drive CyclinB/CDK1-dependent DRP1 Ser616 phosphorylation, mitochondrial fission, and stem-cell self-renewal [#12], represses MKK3 to dampen p38 MAPK signaling [#14], and modulates lineage differentiation, limiting retinoic-acid-induced differentiation in F9 and ES cells [#6, #8]. In cancer contexts REX1 suppresses SOCS1 to activate JAK2/STAT3 and EMT and recruits DNMT3b to methylate and silence RASSF1a, activating MEK/ERK [#7, #13, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established that the Rex-1 promoter is built around an octamer motif essential for activity in stem cells and responsive to retinoic-acid-induced negative regulation, placing the gene under pluripotency-linked control.\",\n      \"evidence\": \"promoter-reporter and octamer site-directed mutagenesis with transgenic lacZ embryo reporters\",\n      \"pmids\": [\"8474450\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the trans-acting factors binding the octamer\", \"No protein-level function for REX1 itself addressed\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identified Oct-3 versus Oct-1 occupancy of the octamer motif as the switch coupling Rex-1 transcription to the undifferentiated state.\",\n      \"evidence\": \"EMSA and supershift across F9, D3, and NT2/D1 cells before and after RA differentiation\",\n      \"pmids\": [\"7945330\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-method binding evidence\", \"No functional knockout of the Oct factors\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Resolved that Oct-3/4 exerts both activating and repressive effects on Rex-1 through separable domains, revealing context-dependent regulation rather than a simple activator relationship.\",\n      \"evidence\": \"promoter deletion/mutation, transient transfection with domain-specific Oct mutants, and EMSA in F9 cells\",\n      \"pmids\": [\"9528758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the Rox-1 positive-element factor unresolved\", \"Mechanism of the activation/repression switch not defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated REX1 is functionally required for proper lineage choice, controlling visceral versus parietal endoderm differentiation in F9 cells.\",\n      \"evidence\": \"homologous-recombination knockout with marker analysis under RA/cAMP conditions\",\n      \"pmids\": [\"12354678\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct target genes identified\", \"Single lineage system\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placed Rex-1 downstream of the pluripotency network by showing Nanog directly activates its promoter with Sox2 cooperation and Oct-3/4 transactivation.\",\n      \"evidence\": \"shRNA knockdown, serial-deletion luciferase reporters, and co-transfection in ES and P19 cells\",\n      \"pmids\": [\"16714766\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect promoter contact not distinguished by ChIP\", \"Combinatorial logic at the element not fully mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined REX1 as a YY1 sub-family C2H2 factor arising by retroposition with a divergent but related DNA-binding specificity, framing its molecular activity.\",\n      \"evidence\": \"phylogenetic analysis and in vitro DNA-binding motif studies\",\n      \"pmids\": [\"17478514\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Primarily comparative/bioinformatic with limited biochemical validation\", \"Genome-wide binding specificity not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linked REX1 to signaling control by showing it restrains JAK/STAT3 activation and SOCS-3 induction in stem cells.\",\n      \"evidence\": \"Rex1-null F9 cells, SOCS-3 promoter luciferase mapping, dominant-negative Src/Jak2/PKA, and phospho-STAT3 western blot\",\n      \"pmids\": [\"18237746\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether REX1 acts directly at signaling-gene promoters not shown\", \"Single cell system\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Broadened REX1's role to dampening multi-germ-layer differentiation and nominated candidate targets in cell cycle and differentiation programs.\",\n      \"evidence\": \"double-knockout ES cells with microarray profiling and re-expression rescue\",\n      \"pmids\": [\"19618472\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Microarray targets lack per-gene mechanistic validation\", \"Direct vs indirect regulation not separated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified MKK3 as a direct REX1 repression target, defining a mechanism by which REX1 suppresses p38 MAPK to control MSC proliferation and lineage balance.\",\n      \"evidence\": \"ChIP at the MKK3 promoter, shRNA knockdown, and p38 inhibitor rescue with differentiation assays\",\n      \"pmids\": [\"20463961\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"No structural basis for promoter recognition\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed YY1 drives human Rex1 and that REX1 positively autoregulates its own promoter, a circuit lost in prostate cancer cells.\",\n      \"evidence\": \"serial-deletion luciferase reporters, co-transfection, and EMSA in NT-2, PrEC, and PC-3 cells\",\n      \"pmids\": [\"20232320\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cause of autoregulation loss in cancer cells not defined\", \"Single-method binding confirmation\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected REX1 to Polycomb-mediated chromatin regulation through binding of bivalent developmental loci and physical interaction with Ring1/RYBP/YAF2.\",\n      \"evidence\": \"ChIP and Co-IP with Ring1A/B, RYBP, and YAF2 in ES versus TS cells\",\n      \"pmids\": [\"21530438\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the interactions on PRC1 activity not measured\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established an in vivo genomic-imprinting function: REX1 protects Peg3 and Gnas DMRs from hypermethylation by allele-specific binding.\",\n      \"evidence\": \"Rex1-null blastocysts with bisulfite sequencing and allele-specific ChIP\",\n      \"pmids\": [\"21233130\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which REX1 binding blocks methylation unknown\", \"Limited to two imprinted domains\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the RNF12–REX1 axis as the trigger of X-chromosome inactivation, showing direct ubiquitination/degradation of REX1 and REX1 occupancy of Xist/Tsix regulatory regions.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, ChIP-seq, and gain/loss-of-function ES cell XCI experiments\",\n      \"pmids\": [\"22596162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How REX1 dosage is quantitatively sensed for XCI timing not fully resolved\", \"Structural basis of RNF12 recognition not shown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended REX1's chromatin role to endogenous retrovirus silencing, showing it represses muERV-L and associates with LSD1/KDM1A.\",\n      \"evidence\": \"ChIP, siRNA depletion in ES cells, embryo microinjection gain/loss-of-function, and Co-IP with LSD1\",\n      \"pmids\": [\"22844087\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct catalytic contribution of LSD1 at REX1 sites not dissected\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided a mechanism for REX1 in human pluripotent self-renewal by directly activating cyclin B1/B2 to drive CyclinB/CDK1–DRP1-dependent mitochondrial fission and glycolysis.\",\n      \"evidence\": \"shRNA knockdown, ChIP at cyclin B1/B2 promoters, phospho-DRP1 western, mitochondrial imaging, and reprogramming assays\",\n      \"pmids\": [\"23939908\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether cyclin regulation is conserved in mouse ES cells not addressed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed REX1 can act oncogenically by directly repressing SOCS1, activating JAK2/STAT3 and driving EMT and metastasis in cervical cancer.\",\n      \"evidence\": \"dual-luciferase reporter, qChIP at the SOCS1 promoter, overexpression, and xenograft metastasis assays\",\n      \"pmids\": [\"31409905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality across other tumor types not tested in this study\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined how the Rex1 super-enhancer is maintained, showing HMGN proteins recruit NANOG/OCT4/SOX2 and preserve enhancer-promoter contacts and active chromatin needed for Rex1 expression and genome-wide REX1 binding.\",\n      \"evidence\": \"ChIP-seq, chromatin conformation capture, and histone-modification profiling in HMGN-knockout ES cells\",\n      \"pmids\": [\"30838422\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HMGN acts on REX1 directly or only through enhancer maintenance not separated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed a methylation-based repression mechanism in which REX1 recruits DNMT3b to silence RASSF1a and activate MEK/ERK, promoting prostate tumor growth.\",\n      \"evidence\": \"Co-IP, ChIP for DNMT3b recruitment, RASSF1a bisulfite methylation analysis, and xenograft model\",\n      \"pmids\": [\"34183450\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Sequence determinants of REX1–DNMT3b targeting unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How REX1's distinct activities — Polycomb/LSD1-linked silencing, DMR protection from methylation, versus DNMT3b-mediated promoter methylation — are differentially deployed at specific loci remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model for when REX1 protects versus promotes methylation\", \"Structural basis of REX1 DNA recognition across target classes not defined\", \"Cofactor selection rules between repressive and activating complexes unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 12, 13, 14, 18]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 10, 12, 14, 15, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 9, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 3, 12, 14]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [9, 10, 11, 18]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 8, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 13, 14, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RNF12\", \"RING1\", \"RYBP\", \"YAF2\", \"KDM1A\", \"DNMT3B\", \"YY1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}